Skip to content

The modified spinal anesthesia combined with epidural technique was evaluated using 22G spinal block needle and epidural pulse infusion for labor analgesia

The modified spinal anesthesia combined with epidural technique was evaluated using 22G spinal block needle and epidural pulse infusion for labor analgesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102950
Enrollment
Unknown
Registered
2025-05-22
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

childbirth

Interventions

Epidural intermittent pulse injection mode (Group E) group:Intraspinal puncture and catheterization were routinely performed at L2-3 and L3-4 intervals, and 5ml of 1% lidocaine was injected. The plane
Spinal anesthesia combined with epidural intermittent pulse injection mode with 22G spinal anesthesia needle (SCSE group):Intraspinal puncture was routinely performed at the interval L2-3 and L3-4. Af
Spinal anesthesia combined with epidural intermittent pulse injection mode with 25G spinal anesthesia needle (SCSE group):Intraspinal puncture was routinely performed at the interval L2-3 and L3-4. Af

Sponsors

Ruian People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Choose 120 full-term pregnant women who actively require painless delivery, who are estimated to be able to deliver naturally via vagina, who have a single head position and no fetal development abnormalities, are pregnant at 37-41 weeks, are in the active phase, and the uterine orifice is10cm.

Exclusion criteria

Exclusion criteria: Premature delivery, multiple pregnancy, pregnancy complicated with severe heart disease, other special chronic diseases, fetal cephalopelvic asymmetry and abnormal fetal position and fetal heart rate

Design outcomes

Primary

MeasureTime frame
Total amount of ropivacaine and sufentanil used;Evaluation of VAS score;Bromage;

Secondary

MeasureTime frame
Self-service pressing times;Call handling times;

Countries

China

Contacts

Public ContactLi Yongliang

Ruian People's Hospital

ralubin@126.com+86 135 0577 5615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026